Invesco’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127K | Buy |
37,112
+12,966
| +54% | +$44.5K | ﹤0.01% | 3615 |
|
|
2025
Q1 | $53.8K | Buy |
24,146
+12,893
| +115% | +$28.8K | ﹤0.01% | 3677 |
|
|
2024
Q4 | $33K | Buy |
11,253
+303
| +3% | +$888 | ﹤0.01% | 3706 |
|
|
2024
Q3 | $28.5K | Sell |
10,950
-2,793
| -20% | -$7.26K | ﹤0.01% | 3716 |
|
|
2024
Q2 | $40.7K | Buy |
13,743
+2,315
| +20% | +$6.85K | ﹤0.01% | 3822 |
|
|
2024
Q1 | $51.8K | Buy |
+11,428
| New | +$51.8K | ﹤0.01% | 3784 |
|
|
2023
Q2 | – | Sell |
-95,208
| Closed | -$718K | – | 3844 |
|
|
2023
Q1 | $718K | Buy |
95,208
+17,017
| +22% | +$128K | ﹤0.01% | 3060 |
|
|
2022
Q4 | $792K | Sell |
78,191
-3,863
| -5% | -$39.1K | ﹤0.01% | 3020 |
|
|
2022
Q3 | $812K | Buy |
82,054
+4,695
| +6% | +$46.5K | ﹤0.01% | 2987 |
|
|
2022
Q2 | $824K | Buy |
+77,359
| New | +$824K | ﹤0.01% | 3063 |
|
|
2021
Q4 | – | Sell |
-28,110
| Closed | -$563K | – | 3988 |
|
|
2021
Q3 | $563K | Buy |
28,110
+13,854
| +97% | +$277K | ﹤0.01% | 3346 |
|
|
2021
Q2 | $314K | Buy |
+14,256
| New | +$314K | ﹤0.01% | 3583 |
|